Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"UGT2B10"”.
-
Metabolism of nicotine and the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): genetic and phenotypic variation.
… Europeans, and among individuals with a variant UGT2B10 genotype. In a controlled dose study of ethnic differences in nicotine metabolism (n= 93 smokers), African Americans excreted 30-40 % less nicotine and cotinine as their glucuronide conjugates than European Americans. This difference in …
-
Nicotine Metabolism and Smoking Behaviour in Vulnerable Populations
… in UDP-glucuronosyltransferase 2B10 and 2B17 (UGT2B10 and UGT2B17) and flavincontaining monooxigenase 3 (FMO3) do not substantially alter nicotine metabolism or tobacco consumption in African Americans. We further demonstrate the metabolism of cotinine, the primary metabolite of nicotine, is …
-
SYSTEM-DEPENDENT METABOLISM OF DRUGS BY CYTOCHROME P450: THE MECHANISTIC BASIS FOR WHY HUMAN LIVER MICROSOMES ARE SUPERIOR TO HUMAN HEPATOCYTES AT METABOLIZING MIDAZOLAM BUT INFERIOR AT METABOLIZING DESLORATADINE
… is converted to an N-glucuronide by UGT2B10. Formation of 3-hydroxydesloratadine could be blocked with inhibitors of either CYP2C8 or UGT2B10. Recombinant CYP2C8 formed 3-hydroxydesloratadine only when co-incubated with recombinant UGT2B10 and HLM formed 3-hydroxydesloratadine only …
-
Caracterización de biomarcadores moleculares de resistencia y sensibilidad a terapia neoadyuvante en cáncer de mama HER2 positivo
… análisis de enriquecimiento funcional reveló que UGT2B10, UGT2B17 y UGT2B28 participaban activamente en varias vías metabólicas críticas, sugiriendo su posible rol en la modulación de la eficacia del tratamiento neoadyuvante. UGT2B10, UGT2B17 y UGT2B28 mostraron diferencias significativas de …
-
The genetic basis of complex diseases: methodologies and applications
… a sub-genome-wide significant singal in the UGT2B10, a multi-acting gene that metabolises endogenous and exogenous substrates and is expressed in hepatic tissues. In the subgroup of the Diabetic cases, with a discriminant characteristic being the presence of Diabetic Nephropathy, we …